[HTML][HTML] Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study
S Nolasco, A Portacci, R Campisi… - Frontiers in …, 2023 - frontiersin.org
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare vasculitis
characterized by asthma, systemic manifestations, and blood and tissue eosinophilia …
characterized by asthma, systemic manifestations, and blood and tissue eosinophilia …
Effectiveness and Safety of Anti-IL-5/Rα Biologics in Eosinophilic Granulomatosis with Polyangiitis: A Two-Year Multicenter Observational Study
S Nolasco, A Portacci, R Campisi, E Buonamico… - 2023 - Eur Respiratory Soc
Background: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare vasculitis
characterized by asthma, systemic manifestations, blood and tissue eosinophilia. Aim: To …
characterized by asthma, systemic manifestations, blood and tissue eosinophilia. Aim: To …
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study.
S Nolasco, A Portacci, R Campisi… - Frontiers in …, 2023 - europepmc.org
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare vasculitis
characterized by asthma, systemic manifestations, and blood and tissue eosinophilia …
characterized by asthma, systemic manifestations, and blood and tissue eosinophilia …
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study
S Nolasco, A Portacci, R Campisi… - FRONTIERS IN …, 2023 - iris.unisa.it
Background: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare vasculitis
characterized by asthma, systemic manifestations, and blood and tissue eosinophilia …
characterized by asthma, systemic manifestations, and blood and tissue eosinophilia …
[PDF][PDF] Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study
S Nolasco, A Portacci, R Campisi, E Buonamico… - 2023 - iris.unict.it
Background: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare vasculitis
characterized by asthma, systemic manifestations, and blood and tissue eosinophilia …
characterized by asthma, systemic manifestations, and blood and tissue eosinophilia …
[HTML][HTML] Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study
S Nolasco, A Portacci, R Campisi… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare vasculitis
characterized by asthma, systemic manifestations, and blood and tissue eosinophilia …
characterized by asthma, systemic manifestations, and blood and tissue eosinophilia …
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study
S Nolasco, A Portacci, R Campisi… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare vasculitis
characterized by asthma, systemic manifestations, and blood and tissue eosinophilia …
characterized by asthma, systemic manifestations, and blood and tissue eosinophilia …
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study
S Nolasco, A Portacci, R Campisi… - FRONTIERS IN …, 2023 - iris.unicz.it
Background: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare vasculitis
characterized by asthma, systemic manifestations, and blood and tissue eosinophilia …
characterized by asthma, systemic manifestations, and blood and tissue eosinophilia …
[PDF][PDF] Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study
S Nolasco, A Portacci, R Campisi, E Buonamico… - 2023 - iris.unict.it
Background: Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare vasculitis
characterized by asthma, systemic manifestations, and blood and tissue eosinophilia …
characterized by asthma, systemic manifestations, and blood and tissue eosinophilia …